Supplements and Featured Publications
The Burden of the Rare Kidney Disorder Focal Segmental Glomerulosclerosis (FSGS)
Modernizing COPD Management: Guideline Evolution, Therapeutic Advances, and Practical Insights
Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations
Clinical and Economic Value of ENTYVIO® (vedolizumab): Implications for Ulcerative Colitis and Crohn Disease Management
Managing HIV in 2025: Optimizing Treatment After Virologic Suppression
Exploring Emerging Therapies in Myasthenia Gravis
Clinical and Economic Considerations for Nivolumab-Based Therapy for Resectable Non–Small Cell Lung Cancer
Continuous Glucose Monitoring as a Driver of Quality and Value: Evidence and Perspectives from Clinical and Managed Care Leaders
The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment
Exploring Novel Treatment Options for Neurofibromatosis Type 1 With Plexiform Neurofibromas
CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data
The Growing Role of Prescription Digital Therapeutics in the Treatment of Psychiatric Disorders
Long-Acting Injectable Administration In Schizophrenia With Insights From Genoa Healthcare® Pharmacy
Alzheimer’s Disease: Advancing Early Diagnosis and Multidisciplinary Care
Guideline-Based Strategies for the Management of Cardiovascular-Renal-Metabolic Conditions: Focus on Chronic Kidney Disease
Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease
Managing Obesity: Strategic Considerations for Payers
Advancing Individualized Care Approaches for Dry Eye Disease
Navigating Cutaneous Squamous Cell Carcinoma: Epidemiological Trends, Treatment Strategies, and Collaborative Care Approaches
Optimizing Management of Metastatic Colorectal Cancer: The Expanding Role of Oncology Pharmacists
The Untold Burden of Uncomplicated UTIs: Addressing Recurrence and Treatment Gaps
Exclusive Coverage of the Conference on Retroviruses and Opportunistic Infections 2025
Coverage of the Conference on Retroviruses and Opportunistic Infections, March 9-12, 2025, San Francisco, California.
Exclusive Coverage of the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Coverage of the Muscular Dystrophy Association Clinical & Scientific Conference, held March 16-19, 2025, in Dallas, Texas.
Moving Beyond SALT Scores: Advancing the Evaluation and Management of Alopecia Areata
Managed Care Considerations for a First-in-Class M1/M4 Muscarinic Agonist for the Treatment of Adults With Schizophrenia
Total Cost of Care Reduction in IDA Patients With Ferric Carboxymaltose
Examining Employer Vaccination Strategies: Highlights From an AJMC® Employer Roundtable
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A
Role of Spevigo® (spesolimab-sbzo) Injection in the Treatment of Generalized Pustular Psoriasis
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
3
How Effective and Safe Are GLP-1s for Weight Loss?
4
Epcoritamab With Rituximab Plus Lenalidomide Approved for R/R Follicular Lymphoma in Second Line
5
